New drug aims to stop second heart attacks in High-Risk patients
NCT ID NCT07208006
Summary
This study is testing if giving a powerful cholesterol-lowering drug (a PCSK9 inhibitor) very early in the hospital, right after a heart attack, can help prevent future heart problems. It will involve about 1,500 people who have had a heart attack and have multiple blocked arteries. The goal is to see if this early, intensive treatment on top of standard care leads to fewer heart attacks, strokes, or deaths over the next year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION (AMI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.